MedTrace Logo

Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients

NCT00337038 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-06-22

No results posted yet for this study

Summary

Our aim is to examine the influence of blood pressure and glycemic control together with N-acetylcystein utilization on the endothelia function of hypertensive diabetic patient.The study population will include 50 diabetic patient with uncontrolled hypertention that will be recruited from the Hypertension Clinic of Soroka University Medical Center.

Conditions

Interventions

DRUG

N-acetylcystein(drug)

p.O t.Siran 200mg x1 during one weak

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Ester Paran, MD · Hypertension Clinic of Soroka University Medical Center

  • Ester Paran, MD · Soroka University Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-07-31
Completion
2010-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00337038 on ClinicalTrials.gov